News

Recent Conference Abstracts

Anti-membrane-IgM monoclonal antibody, mAb4, inhibits the BCRC, modulating downstream signaling pathways.
RS Welt, JA Welt, V Raymond, D Kostyal, & S Welt.
AACR Virtual Special Conference on Tumor Immunology and Immunotherapy, October 19-20, 2020. (See video presentation)

Anti-membrane IgM monoclonal antibody mAb4 is a novel, next-generation BTK inhibitor mediating B-cell leukemia and lymphoma cell death.
RS Welt, JA Welt, V Raymond, D Kostyal, & S Welt.
AACR Virtual Meeting: Advances in Malignant Lymphoma. August 17-19, 2020

Relevant Publications

Specificity and biologic activities of novel anti-membrane IgM antibodies. RS Welt, JA Welt, D Kostyal, YD Gangadharan, V Raymond, & S Welt. Oncotarget, 7(46): 74701. doi: 10.18632/oncotarget.12506